Navigation Links
EORNA Launches First European Accreditation System for Continuous Medical Education of Nursing and Healthcare Professionals
Date:3/9/2009

BRUSSELS, March 9 /PRNewswire/ -- EORNA - the European Operating Room Nurses Organisation - has launched its Accreditation Council for Education (ACE). With ACE, EORNA wants to improve and harmonize the quality of surgical care in Europe. The new ACE is the first European accreditation system for operating room nurses. ACE represents a unique initiative for the professional development of nursing and care in general.

The new ACE will improve the quality and accessibility of continuing education and professional development for nursing and healthcare professionals in Europe. EORNA ACE sets quality standards for distance learning courses and educational events as scientific meetings, conferences, workshops or symposia. Teaching institutes will be able to rely on the ACE quality label and integrate approved courses in their learning plans, thus guaranteeing the latest and accurate information. ACE will also be available to national nursing associations throughout Europe.

After receiving the stamp "EORNA ACE APPROVED", educational courses or events will be able to advertise the label on all materials associated with the course or event. Participating nurses will be able to collect credits points and build their personal continued education program. The review process by the EORNA ACE Board will assure the quality standards of all courses or events.

The system also allows easy exchange of credits between European countries and comparable systems outside Europe, thus improving mobility in the healthcare sector.

EORNA's new ACE will be implemented at its upcoming international Congress "Professional Development - Bridging Perioperative Care", taking place in Copenhagen, Denmark, from 17 - 19 April 2009.

"Educational and training programmes in the nursing sector need alignment and development on a European level. EORNA achieved 1997 to present a curriculum of a minimum of
'/>"/>

SOURCE EORNA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. AdvanceMarketWoRx' Ellen Hoenig Carlson Launches Marketing and Healthcare Blog
3. Glissandra Skincare Inc. Launches Website Showcasing New and Novel Anti-Aging Skincare Products
4. Dr. Praegers Sensible Foods Launches Four New Frozen Food Products
5. Phoenix Health Systems Launches Total Security Program for the Healthcare Industry
6. Samantha Harris Launches A Toast for Everyday Health
7. Nearing Centennial, Occupational Therapy Profession Launches New Brand
8. Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases
9. Bumrungrad Launches 2009 Great Chefs Program - Top local Chefs Design Menus Based on 'Amazing Thailand'
10. Anthem Blue Cross and Blue Shield in Connecticut Launches Innovative New Program for Cities and Towns
11. Nestle Launches State-of-the-Art Factory and Beverage Distribution Center in Anderson, Indiana
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 2Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 3Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 4Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 5Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 6Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 7Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 8Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 9Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 10Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 11Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 12Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 13Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 14Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 15Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 16Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 17Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 18Health News:Rheumatoid Arthritis May Harm Gums 2Health News:Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R) 2Health News:NASA-Enhanced Dust Storm Predictions to Aid Health Community 2Health News:NASA-Enhanced Dust Storm Predictions to Aid Health Community 3
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Brain difference in psychopaths identified 9468 1Brain difference in psychopaths identified 9468 2Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 1Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 2Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 3Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 4Office of National Drug Control Policy Taps RIESTER creative for Use in National Anti Meth Campaign 53622 1Office of National Drug Control Policy Taps RIESTER creative for Use in National Anti Meth Campaign 53622 2